At A Glance
- AOD-9604 is a modified fragment based on a small region of human growth hormone. It was developed to explore fat-related metabolism separately from the full hormone’s growth-related activity.
- Cell and animal work explored whether the fragment could affect fat-related processes separately from full-length HGH.
- AOD-9604 progressed into human development but did not establish an approved weight-loss therapy.
What Is AOD-9604?
AOD-9604 is a modified fragment based on a small region of human growth hormone. It was developed to explore fat-related metabolism separately from the full hormone’s growth-related activity.
The design focuses on the C-terminal region of HGH, with an added tyrosine. Preclinical work explored lipolysis—the breakdown of fat—and fat accumulation. It is a focused fragment approach rather than replacement growth hormone.
Why Is A Small Fragment Interesting?
A larger protein can have several biological roles. Studying one region helps scientists ask whether a particular activity can be separated from the rest. That is the central idea behind AOD-9604’s metabolic research.
Is AOD-9604 The Same As HGH Fragment 176–191?
They are related, but AOD-9604 is modified and the unmodified fragment is a separate material. Its human obesity-development programme also belongs in the story: it did not establish an approved weight-loss treatment. That helps distinguish the original research idea from what clinical development ultimately demonstrated.
A Closer Look At AOD-9604
Here are the key observations and the context that helps explain them. The original sources are linked below if you would like to explore further.
| Study or context | What was explored | What it tells us | Useful context |
|---|---|---|---|
| Preclinical rationale | A lipid-related region of HGH | Cell and animal work explored whether the fragment could affect fat-related processes separately from full-length HGH. | Fragment findings concern the particular sequence tested. |
| Clinical development | The obesity programme | AOD-9604 progressed into human development but did not establish an approved weight-loss therapy. | The clinical history is relevant alongside the earlier laboratory findings. |
Common Questions About AOD-9604
What is AOD-9604?+
AOD-9604 is a modified fragment based on a small region of human growth hormone. It was developed to explore fat-related metabolism separately from the full hormone’s growth-related activity.
Why is a small fragment interesting?+
A larger protein can have several biological roles. Studying one region helps scientists ask whether a particular activity can be separated from the rest. That is the central idea behind AOD-9604’s metabolic research.
Is AOD-9604 the same as HGH Fragment 176–191?+
They are related, but AOD-9604 is modified and the unmodified fragment is a separate material. Its human obesity-development programme also belongs in the story: it did not establish an approved weight-loss treatment. That helps distinguish the original research idea from what clinical development ultimately demonstrated.
Sources
Want to go a little deeper? These links take you to the studies and official records behind the guide. Study registries describe the plan; published papers report the findings.
- Effects of human growth hormone and its lipolytic fragment AOD9604 on lipid metabolism in obese miceEndocrinology · 2001
Primary mouse study of a defined AOD9604 construct. It supports a preclinical metabolic hypothesis, not an approved human weight-loss claim.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
For AOD-9604 context, this official Canadian advisory explains why a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Explore AOD-9604
Review available strengths, pricing, stock status, and product documentation.